Human Neural Stem Cells Encoding ChAT Gene Restore Cognitive Function via Acetylcholine Synthesis, Aβ Elimination, and Neuroregeneration in APPswe/PS1dE9 Mice
Open Access
- 31 May 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (11) , 3958
Abstract
In Alzheimer disease (AD) patients, degeneration of the cholinergic system utilizing acetylcholine for memory acquisition is observed. Since AD therapy using acetylcholinesterase (AChE) inhibitors are only palliative for memory deficits without slowing or reversing disease progress, there is a need for effective therapies, and stem cell-based therapeutic approaches targeting AD should fulfill this requirement. We established a human neural stem cell (NSC) line encoding choline acetyltransferase (ChAT) gene, an acetylcholine-synthesizing enzyme. APPswe/PS1dE9 AD model mice transplanted with the F3.ChAT NSCs exhibited improved cognitive function and physical activity. Transplanted F3.ChAT NSCs in the AD mice differentiated into neurons and astrocytes, produced ChAT protein, increased the ACh level, and improved the learning and memory function. F3.ChAT cell transplantation reduced Aβ deposits by recovering microglial function; i.e., the down-regulation of β-secretase and inflammatory cytokines and up-regulation of Aβ-degrading enzyme neprilysin. F3.ChAT cells restored growth factors (GFs) and neurotrophic factors (NFs), and they induced the proliferation of NSCs in the host brain. These findings indicate that NSCs overexpressing ChAT can ameliorate complex cognitive and physical deficits of AD animals by releasing ACh, reducing Aβ deposit, and promoting neuroregeneration by the production of GFs/NFs. It is suggested that NSCs overexpressing ChAT could be a candidate for cell therapy in advanced AD therapy.Keywords
Funding Information
- National Research Foundation of Korea (2017R1A2A2A05069417)
This publication has 45 references indexed in Scilit:
- Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunctionExperimental Neurology, 2012
- Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammationNeurobiology of Aging, 2012
- Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral SclerosisPLOS ONE, 2012
- Human Neural Stem Cells Overexpressing Choline Acetyltransferase Restore Cognitive Function of Kainic Acid-Induced Learning and Memory Deficit AnimalsCell Transplantation, 2012
- Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's diseaseBehavioural Brain Research, 2011
- The ageing systemic milieu negatively regulates neurogenesis and cognitive functionNature, 2011
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer diseaseProceedings of the National Academy of Sciences, 2009
- Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease MiceThe Journal of Neuroscience, 2008
- BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornixNeuroscience Letters, 2008
- Multilineage Potential of Stable Human Mesenchymal Stem Cell Line Derived from Fetal MarrowPLOS ONE, 2007